PocDoc raises £5m in a seed follow on round from MMC Ventures, Molten VC, Simplyhealth Ventures, and KHP Ventures to fuel growth.
The oversubscribed round was backed by MMC Ventures, Molten VC, Simplyhealth Ventures, and KHP Ventures.
PocDoc provides smartphone based diagnostic technology for cardio, metabolic, and renal screening. The platform delivers near instant health results for patients in community and home settings.
Cambridge based health tech startup PocDoc has secured £5m in a seed follow on funding round. The oversubscribed raise was supported by MMC Ventures, Molten VC, Simplyhealth Ventures, and KHP Ventures. This capital injection brings the company total pre A funding to over £10m. The proceeds will support ongoing commercial growth and deepen public and private sector partnerships.
From the founder
"Today’s announcement of our heavily oversubscribed investment round is a major endorsement of our incredible technology and our journey to date. We are delighted to see such healthy interest in our vision of revolutionising access to screening from the investment community and we’re thrilled to have Molten Ventures, MMC Ventures, and Simplyhealth Ventures investing. The inclusion of KHP Ventures as a fund backed by NHS institutions is a clear signal of our NHS traction and alignment with overall NHS priorities – we couldn’t be happier that they’re investing in our journey."
Steve Roest
CEO and Co founder at PocDoc
Investor perspective
"At KHP Ventures, our focus is on investing in innovators and technologies that are going to deliver the transformation required to deliver the best possible outcomes for patients, staff and health systems, starting with the NHS. PocDoc is demonstrating excellent traction and we’re looking forward to working with Steve, Vlad, Kiran, and the team on the next phase of their growth journey."
Tim Irish
Chair, KHP Ventures
Investors
Categories
About the company
PocDoc
PocDoc provides smartphone based diagnostic testing for cardio, metabolic, and renal diseases.